Preclinical Evaluation of INCB160058 - a Novel and Potentially Disease-Modifying Therapy for JAK2V617F Mutant Myeloproliferative Neoplasms
| Autor(en): | Stubbs, Matthew C. Celik, Hamza Ai, Youxi He, Xin Chang, Hong Lei, Angela Rupar, Mark Wass, Brittney Diamond, Melody Wen, Xiaoming Li, Jun Zolotarjova, Nina Margulis, Alex Trivedi, Gaurang Laranjeira, Angelo Brunelli Albertoni Taylor, Chris Rocha, Jennifer Pollmann, Christoph Piehler, Jacob Ferreira, Bianca Lima Hitchcock, Ian S. Macarrón, Ricardo Yue, Eddy W. Kim, Sunkyu |
Stichwörter: | Ruxolitinib; Myelofibrosis; Janus kinase 2; Cancer research; Biology; Janus kinase; Polycythemia vera; Myeloproliferative Disorders; Kinase; Cell biology; Immunology; Bone marrow | Erscheinungsdatum: | 2023 | Volumen: | 142 | Ausgabe: | Supplement 1 | Startseite: | 860 | Seitenende: | 860 | DOI: | https://doi.org/10.1182/blood-2023-179369 |
Zur Langanzeige
Seitenaufrufe
5
Letzte Woche
0
0
Letzter Monat
4
4
geprüft am 15.05.2024
